JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Waksman, Y.
Right arrow Articles by Cabral, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Waksman, Y.
Right arrow Articles by Cabral, G. A.

Vol. 288, Issue 3, 1357-1366, March 1999

The Central Cannabinoid Receptor (CB1) Mediates Inhibition of Nitric Oxide Production by Rat Microglial Cells1

Yaakov Waksman, John M. Olson, Steven J. Carlisle and Guy A. Cabral

Department of Microbiology and Immunology, Medical College of Virginia of Virginia Commonwealth University, Richmond, Virginia

Upon activation, brain microglial cells release proinflammatory mediators, such as nitric oxide (NO), which may play an important role in the central nervous system antibacterial, antiviral, and antitumor activities. However, excessive release of NO has been postulated to elicit immune-mediated neurodegenerative inflammatory processes and to cause brain injury. In the present study, the effect of cannabinoids on the release of NO from endotoxin/cytokine-activated rat cortical microglial cells was evaluated. A drug dose-dependent (0.1 µM-8 µM) inhibition of NO release from rat microglial cells was exerted by the cannabinoid receptor high-affinity binding enantiomer (-)-CP55940. In contrast, a minimal inhibitory effect was exerted by the lower affinity binding paired enantiomer (+)-CP56667. Pretreatment of microglial cells with the Galpha i/Galpha o protein inactivator pertussis toxin, cyclic AMP reconstitution with the cell-permeable analog dibutyryl-cAMP, or treatment of cells with the Galpha s activator cholera toxin, resulted in reversal of the (-)-CP55940-mediated inhibition of NO release. A similar reversal in (-)-CP55940-mediated inhibition of NO release was effected when microglial cells were pretreated with the central cannabinoid receptor (CB1) selective antagonist SR141716A. Mutagenic reverse transcription-polymerase chain reaction, Western immunoblot assay using a CB1 receptor amine terminal domain-specific antibody, and cellular colocalization of CB1 and the microglial marker Griffonia simplicifolia isolectin B4 confirmed the expression of the CB1 receptor in rat microglial cells. Collectively, these results indicate a functional linkage between the CB1 receptor and cannabinoid-mediated inhibition of NO production by rat microglial cells.


0022-3565/99/2883-1357$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. Zhang and C. Chen
Endocannabinoid 2-Arachidonoylglycerol Protects Neurons by Limiting COX-2 Elevation
J. Biol. Chem., August 15, 2008; 283(33): 22601 - 22611.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. H. Kim, S. J. Won, X. O. Mao, C. Ledent, K. Jin, and D. A. Greenberg
Role for Neuronal Nitric-Oxide Synthase in Cannabinoid-Induced Neurogenesis
J. Pharmacol. Exp. Ther., October 1, 2006; 319(1): 150 - 154.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
P. Pacher, S. Batkai, and G. Kunos
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pharmacol. Rev., September 1, 2006; 58(3): 389 - 462.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. H. Kim, S. J. Won, X. O. Mao, K. Jin, and D. A. Greenberg
Molecular Mechanisms of Cannabinoid Protection from Neuronal Excitotoxicity
Mol. Pharmacol., March 1, 2006; 69(3): 691 - 696.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
G. A. Cabral and F. Marciano-Cabral
Cannabinoid receptors in microglia of the central nervous system: immune functional relevance
J. Leukoc. Biol., December 1, 2005; 78(6): 1192 - 1197.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
B. G. Ramirez, C. Blazquez, T. G. del Pulgar, M. Guzman, and M. L. de Ceballos
Prevention of Alzheimer's Disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockade of Microglial Activation
J. Neurosci., February 23, 2005; 25(8): 1904 - 1913.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
R. B. Rock, G. Gekker, S. Hu, W. S. Sheng, M. Cheeran, J. R. Lokensgard, and P. K. Peterson
Role of Microglia in Central Nervous System Infections
Clin. Microbiol. Rev., October 1, 2004; 17(4): 942 - 964.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. Walter, T. Dinh, and N. Stella
ATP Induces a Rapid and Pronounced Increase in 2-Arachidonoylglycerol Production by Astrocytes, a Response Limited by Monoacylglycerol Lipase
J. Neurosci., September 15, 2004; 24(37): 8068 - 8074.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Scorticati, J. Fernandez-Solari, A. De Laurentiis, C. Mohn, J. P. Prestifilippo, M. Lasaga, A. Seilicovich, S. Billi, A. Franchi, S. M. McCann, et al.
The inhibitory effect of anandamide on luteinizing hormone-releasing hormone secretion is reversed by estrogen
PNAS, August 10, 2004; 101(32): 11891 - 11896.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. Benito, E. Nunez, R. M. Tolon, E. J. Carrier, A. Rabano, C. J. Hillard, and J. Romero
Cannabinoid CB2 Receptors and Fatty Acid Amide Hydrolase Are Selectively Overexpressed in Neuritic Plaque-Associated Glia in Alzheimer's Disease Brains
J. Neurosci., December 3, 2003; 23(35): 11136 - 11141.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Franklin, S. Parmentier-Batteur, L. Walter, D. A. Greenberg, and N. Stella
Palmitoylethanolamide Increases after Focal Cerebral Ischemia and Potentiates Microglial Cell Motility
J. Neurosci., August 27, 2003; 23(21): 7767 - 7775.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M.-T. Samson, A. Small-Howard, L. M. N. Shimoda, M. Koblan-Huberson, A. J. Stokes, and H. Turner
Differential Roles of CB1 and CB2 Cannabinoid Receptors in Mast Cells
J. Immunol., May 15, 2003; 170(10): 4953 - 4962.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. Walter, A. Franklin, A. Witting, C. Wade, Y. Xie, G. Kunos, K. Mackie, and N. Stella
Nonpsychotropic Cannabinoid Receptors Regulate Microglial Cell Migration
J. Neurosci., February 15, 2003; 23(4): 1398 - 1405.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Esposito, A. Ligresti, A. A. Izzo, T. Bisogno, M. Ruvo, M. Di Rosa, V. Di Marzo, and T. Iuvone
The Endocannabinoid System Protects Rat Glioma Cells Against HIV-1 Tat Protein-induced Cytotoxicity. MECHANISM AND REGULATION
J. Biol. Chem., December 20, 2002; 277(52): 50348 - 50354.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Joyeux, C. Arnaud, D. Godin-Ribuot, P. Demenge, D. Lamontagne, and C. Ribuot
Endocannabinoids are implicated in the infarct size-reducing effect conferred by heat stress preconditioning in isolated rat hearts
Cardiovasc Res, August 15, 2002; 55(3): 619 - 625.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
A. C. Howlett, F. Barth, T. I. Bonner, G. Cabral, P. Casellas, W. A. Devane, C. C. Felder, M. Herkenham, K. Mackie, B. R. Martin, et al.
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Pharmacol. Rev., June 1, 2002; 54(2): 161 - 202.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Maccarrone, M. Bari, T. Lorenzon, T. Bisogno, V. Di Marzo, and A. Finazzi-Agro
Anandamide Uptake by Human Endothelial Cells and Its Regulation by Nitric Oxide
J. Biol. Chem., April 28, 2000; 275(18): 13484 - 13492.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics.